Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Recurrence | D012008 | — | — | — | 1 | — | — | — | 1 |
Carcinoma | D002277 | — | C80.0 | — | 1 | — | — | — | 1 |
Lung neoplasms | D008175 | — | C34.90 | — | 1 | — | — | — | 1 |
Small cell lung carcinoma | D055752 | — | — | — | 1 | — | — | — | 1 |
Neuroendocrine tumors | D018358 | EFO_1001901 | D3A.8 | — | 1 | — | — | — | 1 |
Neuroendocrine carcinoma | D018278 | — | — | — | 1 | — | — | — | 1 |
Drug common name | Vicriviroc |
INN | vicriviroc |
Description | (4,6-dimethyl-5-pyrimidinyl)-[4-[(3S)-4-[(1R)-2-methoxy-1-[4-(trifluoromethyl)phenyl]ethyl]-3-methyl-1-piperazinyl]-4-methyl-1-piperidinyl]methanone is a member of (trifluoromethyl)benzenes. |
Classification | Small molecule |
Drug class | antivirals; antivirals, chemokine receptor (CCR) antagonists |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | COC[C@@H](c1ccc(C(F)(F)F)cc1)N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C |
PDB | — |
CAS-ID | 306296-47-9 |
RxCUI | — |
ChEMBL ID | CHEMBL82301 |
ChEBI ID | — |
PubChem CID | 3009355 |
DrugBank | — |
UNII ID | TL515DW4QS (ChemIDplus, GSRS) |